NANOOMTECH Co. Ltd.
KKRX:2448801,679.00
KRW
0.00
(0.00%)
ISIN
KR7244880001
Return %
Stock
S&P 500
1Y
-26.84
14.39
3Y
-47.45
81.42
5Y
-29.90
68.62
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Mu-Jin Choi
- Full Time Employees
- 66
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Gwangju South Korea
- IPO Date
- Jun 1, 2016
- Website
- nanoomtech.co.kr
- Similar Companies
- Business
- NANOOMTECH Co., Ltd. is a South Korea-based medical device manufacturer primarily engaged in the research, development, production, and distribution of emergency resuscitation equipment, diagnostic imaging systems, and therapeutic healthcare devices. Founded in 2005 and headquartered in Gwangju, South Korea, the company operates across specialized medical sectors, serving public safety organizations, emergency medical services, hospitals, private clinics, commercial institutions, and government bodies. The company organizes its principal product and service offerings into four core business segments: Automated External Defibrillators, Bone Mineral Densitometry Systems, Physical Therapy and Rehabilitation Equipment, and Medical Accessories and Consumables. Under its flagship automated external defibrillator (AED) line, marketed primarily under the Heart Plus and ReHeart brand names, the company manufactures portable biphasic defibrillators, including the NT-180, NT-280, and NT-381 series, configured for both adult and pediatric cardiac resuscitation; educational CPR trainers and simulation units; and integrated smart AED storage stations featuring automated climate control and remote alarm monitoring. In its diagnostic segment, NANOOMTECH manufactures ultrasound bone mineral densitometers under the OsteoPro brand, including the OsteoPro Smart and OsteoPro Easy series, utilized in the early screening, measurement, and diagnosis of osteoporosis. Its therapeutic and physical medicine portfolio comprises extracorporeal shockwave therapy (ESWT) devices; neuromuscular low-frequency and high-frequency electrotherapy units; and targeted magnetic stimulation equipment for musculoskeletal pain management and rehabilitation. Additionally, the company supplies critical proprietary consumables and accessories, including single-use adult and pediatric defibrillation electrode pads; high-capacity replacement battery packs; ECG patient cables; and device calibration phantoms. NANOOMTECH conducts commercial operations throughout South Korea and maintains an international sales footprint spanning more than 40 countries across Asia, Europe, the Middle East, and Latin America through authorized medical device distributors, public tenders, and OEM/ODM partnerships. In recent developments, NANOOMTECH has expanded its technological offerings through the introduction of next-generation IoT-connected AED platforms featuring real-time central fleet monitoring, automated status self-testing, and mobile emergency notification integration. The company has also pursued international regulatory advancements, including compliance adaptation for European Medical Device Regulation (EU MDR) certification, and forged strategic distribution partnerships to accelerate market penetration across Southeast Asia and the Middle East. Furthermore, NANOOMTECH has upgraded manufacturing lines and cleanroom facilities at its Gwangju production base while advancing operational and corporate initiatives to support its strategic migration from the KONEX market to the KOSDAQ board.